Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1981 3
1983 3
1984 5
1985 6
1986 9
1987 6
1988 2
1989 1
1990 2
1994 1
1995 3
1999 1
2007 1
2008 1
2010 1
2012 2
2013 3
2015 5
2016 2
2017 2
2018 2
2019 1
2020 2
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators. Scirica BM, et al. N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2. N Engl J Med. 2013. PMID: 23992601 Free article. Clinical Trial.
Deubiquitinases: key regulators of the circadian clock.
Harris-Gauthier N, Srikanta SB, Cermakian N. Harris-Gauthier N, et al. Among authors: srikanta sb. Am J Physiol Cell Physiol. 2022 Nov 1;323(5):C1539-C1547. doi: 10.1152/ajpcell.00289.2022. Epub 2022 Oct 3. Am J Physiol Cell Physiol. 2022. PMID: 36189971 Free article. Review.
Management of anemia in patients with diabetic kidney disease: A consensus statement.
Bajaj S, Makkar BM, Abichandani VK, Talwalkar PG, Saboo B, Srikanta SS, Das A, Chandrasekaran S, Krishnan PV, Shah A, Abraham G, Tikku P, Kumar S. Bajaj S, et al. Among authors: srikanta ss. Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):268-81. doi: 10.4103/2230-8210.176348. Indian J Endocrinol Metab. 2016. PMID: 27042425 Free PMC article. Review.
Pre-hyperglycemic diabetes mellitus.
Soeldner JS, Srikanta S, Eisenbarth GS, Gleason RE. Soeldner JS, et al. Among authors: srikanta s. Clin Chem. 1986 Oct;32(10 Suppl):B7-18. Clin Chem. 1986. PMID: 3530543 Review. No abstract available.
68 results